title: Will adjuvant antiviral therapy close the outcome gap between liver transplantation and resectional therapy for hepatitis B virus-associated hepatocellular cancer?: The answer is in reach.
authors.affiliation: Department of Surgery, The Johns Hopkins University, Baltimore, MD 21287, USA. cwolfga2@jhmi.edu
authors.forename: Christopher
authors.initials: C
authors.lastname: Wolfgang
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery* / Q000821:virology; D006498:Hepatectomy; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery* / Q000821:virology; D016031:Liver Transplantation; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents